GPX2 and pancreatic neoplasm: In addition, cluster 5/GPx2 KD up-regulated S100 genes, known to play a role in metastatic fitness of pancreatic tumors (57), and galectin genes, which may guide therapeutic resistance, and hence tumor recurrence or metastasis (39).